Research News - Metastatic Breast Cancer Trial Talk

Research News

Oral SERDs for Estrogen Receptor-Positive MBC

An oral selective estrogen receptor degrader ( SERD) is a type of anti-hormone therapy for treating ER-positive metastatic breast cancer. Understand how it works, the current status of and future directions for oral SERD research.  

Read More


for past articles or specific information.